Former Member of the Scottish Parliament

Ian McKee

Unknown party

At a glance Ian McKee was a Member of the Scottish Parliament.

Questions93 tabled

Ian McKee has tabled 93 questions in the Scottish Parliament.

To ask the Scottish Executive when it will next meet representatives of NHS Lothian. 24 Feb 2011 · General Question

To ask the Scottish Executive when it will next meet representatives of NHS Lothian.

Answer · Nicola Sturgeon · 24 Feb 2011

Ministers and Government officials meet representatives of all NHS boards on a regular basis. Forthcoming meetings with representatives of NHS Lothian will cover a wide range of matters of current interest to the NHS in Scotland in general and to NHS Lothian in particular.</b></p>

To ask the Scottish Executive which NHS boards provide funding for eculizumab for the treatment of paroxysmal nocturnal… 11 Feb 2011 · Written Question

To ask the Scottish Executive which NHS boards provide funding for eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria.

Answer · Nicola Sturgeon · 3 Mar 2011

Eculizumab is not recommended by the Scottish Medicines Consortium for use within NHSScotland. As a result, each individual case needs to be considered by the host NHS board according to the specific needs of each individual patient.</b></p> <p >Information is available for Scottish patients in the care of the UK designated specialist service at the outreach clinic in Monklands Hospital, Lanarkshire. At present, eculizumab has been approved for the treatment of individual patients with paroxysmal nocturnal haemoglobinuria in five areas - NHS Lanarkshire, NHS Forth Valley, NHS Ayrshire and Arran, NHS Greater Glasgow and Clyde and NHS Lothian.</p>

To ask the Scottish Executive how many patients with paroxysmal nocturnal haemoglobinuria are treated with eculizumab. 11 Feb 2011 · Written Question

To ask the Scottish Executive how many patients with paroxysmal nocturnal haemoglobinuria are treated with eculizumab.

Answer · Nicola Sturgeon · 3 Mar 2011

Seven Scottish patients with paroxysmal nocturnal haemoglobinuria are currently treated with eculizumab through the UK designated specialist service, which provides an outreach clinic in Monklands Hospital, Lanarkshire.</b></p>

To ask the Scottish Executive what initial resources are being made available to NHS boards and Special Health Boards i… 10 Feb 2011 · Written Question

To ask the Scottish Executive what initial resources are being made available to NHS boards and Special Health Boards in 2011-12.

Answer · Nicola Sturgeon · 11 Feb 2011

NHS boards revenue resource funding will increase overall by 3.2% in 2011-12. Special Health Boards receive an general uplift of 1%; a differential efficiency target has been set for Special Health Boards services not delivering direct patient care to improve efficiency and support funding front-line services.</b></p> <p >Details of NHS boards and Special Health Boards initial revenue resource allocations for 2011-12 are as follows:</p> <table border=1 cellspacing=0 cellpadding=0 > <thead> <tr > <td nowrap valign=top > <p >&nbsp;</p> </td> <td nowrap valign=top > <p align=center >Initial Allocation</p> <p align=center >2011-12</p> <p align=center >£ million</p> </td> <td nowrap valign=top > <p align=center >Uplift</p> <p align=center >2011-12</p> <p align=center >%</p> </td> </tr> </thead> <tr > <td nowrap valign=top > <p align=left >NHS Ayrshire and Arran</p> </td> <td nowrap valign=top > <p align=right >574.7</p> </td> <td nowrap valign=top > <p align=right >2.8%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Borders</p> </td> <td nowrap valign=top > <p align=right >167.3</p> </td> <td nowrap valign=top > <p align=right >2.9%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Dumfries and Galloway</p> </td> <td nowrap valign=top > <p align=right >241.7</p> </td> <td nowrap valign=top > <p align=right >2.9%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Fife </p> </td> <td nowrap valign=top > <p align=right >507.1</p> </td> <td nowrap valign=top > <p align=right >3.1%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Forth Valley</p> </td> <td nowrap valign=top > <p align=right >402.8</p> </td> <td nowrap valign=top > <p align=right >3.2%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Grampian </p> </td> <td nowrap valign=top > <p align=right >691.1</p> </td> <td nowrap valign=top > <p align=right >3.8%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Greater Glasgow and Clyde</p> </td> <td nowrap valign=top > <p align=right >1,895.6</p> </td> <td nowrap valign=top > <p align=right >2.7%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Highland</p> </td> <td nowrap valign=top > <p align=right >484.8</p> </td> <td nowrap valign=top > <p align=right >3.0%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Lanarkshire </p> </td> <td nowrap valign=top > <p align=right >815.6</p> </td> <td nowrap valign=top > <p align=right >3.2%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Lothian </p> </td> <td nowrap valign=top > <p align=right >1,054.4</p> </td> <td nowrap valign=top > <p align=right >4.2%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Orkney </p> </td> <td nowrap valign=top > <p align=right >31.5</p> </td> <td nowrap valign=top > <p align=right >3.0%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Shetland</p> </td> <td nowrap valign=top > <p align=right >36.7</p> </td> <td nowrap valign=top > <p align=right >2.9%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Tayside</p> </td> <td nowrap valign=top > <p align=right >596.4</p> </td> <td nowrap valign=top > <p align=right >2.9%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >NHS Western Isles</p> </td> <td nowrap valign=top > <p align=right >57.7</p> </td> <td nowrap valign=top > <p align=right >2.7%</p> </td> </tr> <tr > <td nowrap valign=top > <p align=left >Total NHS Boards</p> </td> <td nowrap valign=top > <p align=right >7,557.4</p> </td> <td nowrap valign=top >

To ask the Scottish Executive how much funding (a) it and (b) its agencies have given to the Scottish Football Associa… 9 Feb 2011 · Written Question

To ask the Scottish Executive how much funding (a) it and (b) its agencies have given to the Scottish Football Association and other football governing bodies in each of the last 10 years for which information is available and on what contractual basis

Answer · Shona Robison · 9 Mar 2011

In the three years from 2008-09, the Scottish Football Association was awarded £2.535 million direct from the Scottish Government to deliver a wide range of football opportunities as part of the Cashback for Communities programme. A further £2 million has been provided from the Cashback for Communities programme to sportscotland to help support the delivery of quality facilities in communities across Scotland.</p> <p >The Scottish Football Association has received significant funding from sportscotland in each of the last ten years to support the implementation of the sport''s development plan. The level of investment is an operational matter and I have asked the chief executive of sportscotland, Stewart Harris, to provide the detailed information requested.</p>

To ask the Scottish Executive how much funding (a) it and (b) its agencies have given to Scottish Rugby Union in each o… 28 Jan 2011 · Written Question

To ask the Scottish Executive how much funding (a) it and (b) its agencies have given to Scottish Rugby Union in each of the last 10 years for which information is available and what the contractual basis was for such payments.

Answer · Shona Robison · 8 Feb 2011

In the three years from 2008-09, Scottish Rugby was awarded £1.415 million direct from the Scottish Government to deliver a wide range of rugby opportunities as part of the government''s Cashback for Communities programme.</b></p> <p >Scottish Rugby has received significant funding from sportscotland in each of the last ten years to support the implementation of the sport''s development plan. The level of investment is an operational matter and I have asked the Chief Executive of sportscotland, Stewart Harris, to provide the detailed information requested.</p>

To ask the Scottish Executive what plans it has to create a cancer drugs fund to improve access to ultra-orphan treatme… 1 Nov 2010 · Written Question

To ask the Scottish Executive what plans it has to create a cancer drugs fund to improve access to ultra-orphan treatments.

Answer · Nicola Sturgeon · 11 Nov 2010

The Scottish Government will give due consideration to the Department of Health cancer drugs fund consultation findings once they are published.</b></p> <p >Scotland has robust, equitable and transparent arrangements for the introduction of newly licensed clinically and cost-effective medicines to treat all conditions, including rare diseases. The arrangements include opportunities at local level for clinically led consideration of medicines for individual patients in certain circumstances.</p> <p >In appraising orphan medicines to treat rare diseases, the Scottish Medicines Consortium (SMC) may, in addition to the standard assessment of clinical and cost-effectiveness, apply modifiers which consider other additional factors. subject to meeting certain criteria, this can facilitate acceptance of a medicine notwithstanding the economic evidence provided. Full details on SMC policies can be found on the SMC website at:</p> <p >http://www.scottishmedicines.org.uk/smc/3863.21.24.html.</p>

To ask the Scottish Executive whether it plans to make extra funds available or adapt the existing Scottish Medicines C… 1 Nov 2010 · Written Question

To ask the Scottish Executive whether it plans to make extra funds available or adapt the existing Scottish Medicines Consortium health technology assessment process in order to improve access to ultra-orphan treatments.

Answer · Nicola Sturgeon · 11 Nov 2010

The Scottish Government currently has no plans to make extra funds available. The Scottish Medicines Consortium (SMC) gives due consideration to its processes on a regular basis.</b></p> <p >Scotland has a robust, equitable and transparent arrangements for the introduction of newly licensed clinically and cost-effective medicines to treat all conditions, including rare diseases. The arrangements include opportunities at local level for clinically led consideration of medicines for individual patients in certain circumstances.</p> <p >In appraising orphan medicines to treat rare diseases, the SMC may, in addition to the standard assessment of clinical and cost-effectiveness, apply modifiers which consider other additional factors. Subject to meeting certain criteria, this can facilitate acceptance of a medicine notwithstanding the economic evidence provided. Full details on SMC policies can be found on the SMC website at:</p> <p >http://www.scottishmedicines.org.uk/smc/3863.21.24.html.</p>

See all questions

Motions lodged77 lodged
Seat & career1 seat held

Source: this MSP's profile on parliament.scot.

Source: this MSP's official Scottish Parliament profile. Last updated 26 Jul 2026.